NASA Selects Blue Origin Over SpaceX for Critical Moon Base Mission New York Times Pips Puzzle Game Expands Digital Offerings Potential for Subscriber Engagement Growth Jim Cramer Highlights Stock Opportunities with Potential Upside in Morning Meeting Plus500 Reports 11 Quarterly Revenue Rise Affirms FullYear Outlook BofA Increases Philip Morris International Price Target by 9 Cites Strong Outlook BioOrbit Launches Drug Crystallization Technology on SpaceX to Space Station Targeting SelfInjected Cancer Treatments Baidu Q1 2026 Earnings EPS Beats Estimates but Stock Slides Amid Revenue Uncertainty Theriva Biologics TOVX Q1 2026 Earnings Narrowed Loss Beats Expectations as Stock Rises 51Talk COE Q3 2025 Earnings Wider Loss Weighs on Shares as Revenue Details Remain Unclear agilon health Q1 2026 Earnings Massive EPS Beat Drives Stock Surge Fidelity D D Bancorp FDBC Q4 2025 Earnings Solid EPS of 137 Amid Quiet Market Reaction B2Gold Corp BTG Holds Steady Near Support as Gold Prices Fluctuate Genesco GCO Slips Nearly 3 as Footwear Retail Headwinds Weigh on Sentiment Jackson Acquisition Company II JACS Holds Steady at 1061 Amid Narrow Trading Range Bakkt BKKT Faces Selling Pressure as Shares Decline 357 Amid Volatile Trading GE Q1 2026 Earnings EPS Beat Drives Slight Stock Uptick Amid Operational Focus New Pacific Metals Corp NEWP Q1 2026 Earnings EPS Miss Marks Quarter of Operational Progress Amid Narrowing Losses TYRA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment Prelude Therapeutics Q1 2026 Earnings Significant EPS Beat Amid No Revenue Two Harbors Investment Corp Q1 2026 Earnings Strong EPS Beat Amid Stable Interest Rate Environment Natural Resource Partners LP NRP Q1 2026 Earnings Solid EPS Amid Flat Revenue and Slight Stock Dip Political Realignment in Tamil Nadu Three AIADMK MLAs Resign May Join VijayLed Party Prelude Therapeutics Q1 2026 Earnings Significant EPS Beat Amid No Revenue